Myocarditis<\/b> is an inflammatory disease of the muscle layer of the heart, the myocardium, which can clinically manifest itself in different syndromes.<\/p>\n
Symptoms may include fatigue, fever, night sweats, joint pain, or weight loss.
\nSymptoms of acute mycarditis appear after a few hours and last for about seven days. For example, pain in the middle of the chest, which worsens when taking a deep breath, and calms down when sitting; neck and shoulder pain; fever; in the chronic phase, the heart may not be able to pump blood properly, and it may progress to heart failure.<\/p>\n
Cases of adolescents and young adults developing myocarditis after vaccination with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccines have been reported worldwide.<\/span><\/span><\/span><\/p>\n https:\/\/www.ahajournals.org\/doi\/10.1161\/CIRCULATIONAHA.122.061025<\/a><\/p>\n This is research<\/a> aimed to investigate the immune profiles of adolescents and young adults who developed myocarditis after receiving the vaccine.<\/span><\/span> Researchers prospectively collected blood samples from 16 patients who were hospitalized with myocarditis after receiving the SARS-CoV-2 vaccine and compared them with 45 healthy, age-matched vaccinated control subjects.<\/span><\/span> They performed extensive antibody profiling, including tests of humoral responses specific to SARS-CoV-2 and assessments of autoantibodies or antibodies against other viruses.<\/span><\/span> They also analyzed T-cell responses and cytokine production in blood samples.<\/span><\/span> They found that the immune responses induced by the mRNA vaccine did not differ between patients who developed myocarditis and control subjects.<\/span><\/span> However, they found that patients with myocarditis had higher levels of free, unbound spike proteins in their blood, which may be a potential cause of myocarditis in these individuals.<\/span><\/span><\/span><\/p>\n The study looked at sixty-one adolescents and young adults between the ages of 12 and 21, including 16 with vaccine-related myocarditis, with blood samples for analysis.<\/span><\/span> Most people with myocarditis were men, and symptoms usually appeared within the first week after vaccination.<\/span><\/span> Most of these people developed myocarditis after the second dose of the vaccine, but some developed it after the first or third booster dose.<\/span><\/span> All patients presented with chest pain and had elevated levels of cardiac troponin T and C-reactive protein.<\/span><\/span> The researchers compared the serological responses of individuals with myocarditis to those of asymptomatic vaccinated control subjects and found no significant differences in levels of anti-spike or anti-RBD immunoglobulin M, IgG, or IgA, or in the ability of antibodies to engage Fc<\/span><\/span> receptors or activate complement.<\/span><\/span> They also found no significant levels of autoantibodies or strong antibody responses to common pathogens in the myocarditis group compared to the control group.<\/span><\/span> <\/span><\/p>\n The myocarditis group also had cytokine profiles similar to those seen in a condition called MIS-C (multisystem inflammatory syndrome in children), with elevated levels of interleukin (IL)-8, IL-6, tumor necrosis factor-\u03b1, IL-<\/span><\/span> 10, interferon-\u03b3 and IL-1\u03b2, and lower levels of IL-4 compared to the control group.<\/span><\/span> Additionally, the total number of leukocytes and neutrophils significantly increased in the group with myocarditis, while the number of platelets decreased.<\/span><\/span> These results suggest that post-vaccination myocarditis is associated with normal adaptive and T-cell immunity but modest innate activation.<\/span><\/span><\/span><\/p>\n Another study published:<\/p>\n New Taiwanese study finds high rate of cardiac side effects in high school students after 2nd dose of Pfizer.\u201c4928 (62,1%) were included in the study. The ratio of men to women was 4576\/352. A total of 763 students (17.1%) had at least one cardiac symptom after the second dose of the vaccine, mainly chest pain and palpitations. An abnormal ECG was obtained in 51 (1.0%) students, 1 of whom had been diagnosed with mild myocarditis, and for another 4 were assessed as having significant arrhythmia.<\/p>\n Source: https:\/\/pubmed.ncbi.nlm.nih.gov\/36602621\/<\/a><\/p>\n Cleanse your body with a 5-day gut and blood detox that is now on sale, you can read more about that package HERE<\/a>.<\/p>\n For prevention, we suggest compliance A healthy lifestyle<\/a> and the formula for the protection of blood vessels and the heart, you can read about that formula HERE<\/a>.<\/p>\n